These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32472918)

  • 41. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic validity of dichotic multiple frequencies auditory steady-state responses versus distortion product otoacoustic emissions in hearing screening of high risk neonates.
    Mahmoudian S; Farhadi M; Kadivar M; Ghalehbaghi B; Rahimi F; Hemami MR; Kamrava SK; Asghari A; Amintehran E; Mohagheghi P
    Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1109-16. PubMed ID: 21719120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-related declines in distortion product otoacoustic emissions utilizing pure tone contralateral stimulation in CBA/CaJ mice.
    Varghese GI; Zhu X; Frisina RD
    Hear Res; 2005 Nov; 209(1-2):60-7. PubMed ID: 16061336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses.
    Rosner T; Kandzia F; Oswald JA; Janssen T
    J Acoust Soc Am; 2011 Feb; 129(2):840-51. PubMed ID: 21361442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of Chronic Tinnitus in Noise-Induced Hearing Loss and Presbycusis.
    Kang HJ; Kang DW; Kim SS; Oh TI; Kim SH; Yeo SG
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33921850
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of TEOAE and DPOAE measurements for the assessment of auditory thresholds in sensorineural hearing loss.
    Suckfüll M; Schneeweiss S; Dreher A; Schorn K
    Acta Otolaryngol; 1996 Jul; 116(4):528-33. PubMed ID: 8831837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions.
    Md Daud MK; Mohamadl H; Haron A; Rahman NA
    B-ENT; 2014; 10(1):53-8. PubMed ID: 24765829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A validation and potential clinical application of multivariate analyses of distortion-product otoacoustic emission data.
    Gorga MP; Dierking DM; Johnson TA; Beauchaine KL; Garner CA; Neely ST
    Ear Hear; 2005 Dec; 26(6):593-607. PubMed ID: 16377995
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Distortion product otoacoustic emissions (DPOAE) in chronic noise-induced hearing loss--recommendations for expert assessment].
    Oeken I; Müller H
    Laryngorhinootologie; 1995 Aug; 74(8):473-80. PubMed ID: 7575898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Is otoacoustic emission useful in the differential diagnosis of occupational noise-induced hearing loss?].
    Sliwińska-Kowalska M; Kotylo P
    Med Pr; 1997; 48(6):613-20. PubMed ID: 9558629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measuring of distortion product otoacoustic emissions using multiple tone pairs.
    Kastanioudakis I; Ziavra N; Anastasopoulos D; Skevas A
    Eur Arch Otorhinolaryngol; 2003 Aug; 260(7):395-400. PubMed ID: 12937915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between pure tone audiometry at all frequencies and distortion product otoacoustic emission of patients with hidden hearing loss.
    Ding Y; Liu Y; Li D; Hu R; Tian Z; Xie Q
    Biotechnol Genet Eng Rev; 2024 Dec; 40(4):4250-4261. PubMed ID: 37171371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-sectional age-changes of hearing in the elderly.
    Gates GA; Feeney MP; Mills D
    Ear Hear; 2008 Dec; 29(6):865-74. PubMed ID: 18998241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transiently evoked and distortion-product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears.
    Probst R; Harris FP
    Arch Otolaryngol Head Neck Surg; 1993 Aug; 119(8):858-60. PubMed ID: 8343248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Otoacoustic emissions in a hearing conservation program: general applicability in longitudinal monitoring and the relation to changes in pure-tone thresholds.
    Helleman HW; Jansen EJ; Dreschler WA
    Int J Audiol; 2010 Jun; 49(6):410-9. PubMed ID: 20192875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.